XAGE2, which has not been reported in the literature in BLCA, is considered a cancer/testis-associated gene, and is frequently found to be aberrantly expressed in melanoma and Ewing sarcoma20, therefore it was the first time revealed in this study to be associated with the prognosis of BLCA patients. This evidence concerns the gene XAGE2 and bladder transitional cell carcinoma.